← Home
FoundMyFitness · February 28, 2023 · 1h 48m

#079 Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Dementia | Axel Montagne, Ph.D.

Dr. Axel Montagne discusses the role of the blood-brain barrier in dementia, explaining that vascular dysfunction is a common thread across Alzheimer’s and other dementias. He covers the impact of the APOE4 genotype on brain vasculature, the protective effects of high heart rate exercise, and the surprising finding that a hepatitis drug restored cognition in APOE4 mice. The conversation reveals how leaky vessels damage myelin and why preserving vascular health could be key to prevention.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Curious

Exercise that raises the heart rate helps maintain the blood-brain barrier, protecting both brain and vision health through vascular shear stress.

Highlights

Vascular dysfunction as a common thread in dementia00:11:44
Montagne explains that the breakdown of small blood vessels is a shared pathology across different dementias, making vascular health a central target for prevention.
APOE4 genotype and blood-brain barrier breakdown00:18:54
The APOE4 allele, the strongest genetic risk factor for late-onset Alzheimer’s, may accelerate dementia by damaging the brain’s small vessels and pericytes.
Hepatitis drug restores cognition in APOE4 mice01:14:35
A drug originally developed for hepatitis reversed cognitive deficits in mice carrying the human APOE4 gene, highlighting vascular-targeted repurposing.
Leaky blood-brain barrier damages myelin and causes white matter lesions00:40:17
When the barrier leaks, blood proteins like fibrinogen enter the brain and trigger inflammation that strips myelin, leading to white matter damage.

Misc

A drug originally developed for hepatitis restored cognitive function in mice carrying the APOE4 gene.
High-intensity exercise that elevates heart rate may help preserve vision health by protecting the retinal barrier.
APOE4 carriers may develop leaky blood vessels in the brain during the earliest stages of cognitive decline.
Was this useful?